Insider · CIK 0001793992

Gaspar Bobby

Reports to the SEC for 1 company · LONDON, X0

sec.gov

Transactions

Companies

Filings

CIK

0001793992

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−582K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−427K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−563K sh	—	—	0
2024-01-24	Orchard Therapeutics plcD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−366K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−598K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−40K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−96.4K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−50K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−200K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−300K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−850K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−55K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−423K sh	—	—	0
2023-03-01	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+582K sh	—	—	581,590
2023-03-01	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+563K sh	—	—	563,410
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+50K sh	—	—	50,000
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−200K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−300K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+55K sh	—	—	55,006
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−55K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+850K sh	—	—	850,000
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−850K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−50K sh	—	—	0
2022-06-01	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+427K sh	—	—	427,369
2022-06-01	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+423K sh	—	—	422,631
2022-04-01	Orchard Therapeutics plcP Purchase	Director, Chief Executive Officer	PPurchase	+15K sh	$0.74	+$11.1K	366,158
2021-02-01	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+850K sh	—	—	850,000
2021-02-01	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+55K sh	—	—	55,006
2021-01-11	Orchard Therapeutics plcF Tax Payment	Director, Chief Executive Officer	FTax Payment	−3,411 sh	$6.72	−$22.9K	351,158
2021-01-08	Orchard Therapeutics plcA Award	Director, Chief Executive Officer	AAward	+6,250 sh	—	—	354,569
2020-04-01	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2020-03-02	Orchard Therapeutics plcStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−4,921 sh	—	—	597,867
2020-03-02	Orchard Therapeutics plcM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+4,921 sh	$0.00	+$0.492	353,240
2020-03-02	Orchard Therapeutics plcS Sale	Director, Chief Executive Officer	SSale	−4,921 sh	$13.00	−$64K	348,319
2020-01-02	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Jan 244
Gaspar Bobby0000950170-24-007058
SEC(opens sec.gov)
Mar 34
Gaspar Bobby0001209191-23-015879
SEC(opens sec.gov)
Oct 64
Gaspar Bobby0001209191-22-053004
SEC(opens sec.gov)

Companies

Orchard Therapeutics plcDirector, Chief Executive Officer

Address

C/O ORCHARD THERAPEUTICS PLC 108 CANNON STREET

LONDON, X0, EC4N 6EU